BlackRock’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $328M | Buy |
5,640,118
+539,834
| +11% | +$24.9M | 0.01% | 1382 |
|
|
2025
Q4 | $229M | Buy |
5,100,284
+329,333
| +7% | +$13.8M | ﹤0.01% | 1596 |
|
|
2025
Q3 | $192M | Sell |
4,770,951
-594,376
| -11% | -$20.9M | ﹤0.01% | 1685 |
|
|
2025
Q2 | $168M | Buy |
5,365,327
+3,329,202
| +164% | +$109M | ﹤0.01% | 1730 |
|
|
2025
Q1 | $68.3M | Sell |
2,036,125
-69,111
| -3% | -$2.62M | ﹤0.01% | 2216 |
|
|
2024
Q4 | $82.5M | Sell |
2,105,236
-326
| -0% | -$13.5K | ﹤0.01% | 2184 |
|
|
2024
Q3 | $82.9M | Buy |
2,105,562
+9,668
| +0.5% | +$390K | ﹤0.01% | 2189 |
|
|
2024
Q2 | $81.7M | Sell |
2,095,894
-26,034
| -1% | -$1.04M | ﹤0.01% | 2144 |
|
|
2024
Q1 | $91.3M | Buy |
2,121,928
+54,865
| +3% | +$2.52M | ﹤0.01% | 2104 |
|
|
2023
Q4 | $95.2M | Buy |
2,067,063
+1,075,606
| +108% | +$38M | ﹤0.01% | 2109 |
|
|
2023
Q3 | $33.9M | Sell |
991,457
-2,583
| -0.3% | -$96.6K | ﹤0.01% | 2632 |
|
|
2023
Q2 | $38.3M | Buy |
994,040
+94,886
| +11% | +$3.77M | ﹤0.01% | 2651 |
|
|
2023
Q1 | $32.2M | Sell |
899,154
-26,469
| -3% | -$978K | ﹤0.01% | 2715 |
|
|
2022
Q4 | $36.5M | Sell |
925,623
-116,906
| -11% | -$4.26M | ﹤0.01% | 2685 |
|
|
2022
Q3 | $37.6M | Buy |
1,042,529
+174,239
| +20% | +$6.26M | ﹤0.01% | 2665 |
|
|
2022
Q2 | $26.4M | Buy |
868,290
+253,333
| +41% | +$7.66M | ﹤0.01% | 2931 |
|
|
2022
Q1 | $18.8M | Buy |
614,957
+47,385
| +8% | +$1.42M | ﹤0.01% | 3207 |
|
|
2021
Q4 | $17.7M | Buy |
567,572
+124,520
| +28% | +$3.72M | ﹤0.01% | 3346 |
|
|
2021
Q3 | $6.77M | Buy |
443,052
+31,800
| +8% | +$553K | ﹤0.01% | 3843 |
|
|
2021
Q2 | $7.66M | Buy |
411,252
+13,129
| +3% | +$242K | ﹤0.01% | 3742 |
|
|
2021
Q1 | $7.13M | Sell |
398,123
-21,420
| -5% | -$363K | ﹤0.01% | 3767 |
|
|
2020
Q4 | $6.45M | Buy |
419,543
+350,651
| +509% | +$4.1M | ﹤0.01% | 3586 |
|
|
2020
Q3 | $763K | Sell |
68,892
-251
| -0.4% | -$2.95K | ﹤0.01% | 4178 |
|
|
2020
Q2 | $866K | Buy |
69,143
+61,436
| +797% | +$782K | ﹤0.01% | 4076 |
|
|
2020
Q1 | $87K | Buy |
+7,707
| New | +$110K | ﹤0.01% | 4377 |
|
|
2019
Q4 | – | Sell |
-256,667
| Closed | -$2.31M | – | 5092 |
|
|
2019
Q3 | $2.31M | Sell |
256,667
-1,947
| -0.8% | -$18.4K | ﹤0.01% | 3704 |
|
|
2019
Q2 | $2.55M | Sell |
258,614
-8,963
| -3% | -$85.8K | ﹤0.01% | 3697 |
|
|
2019
Q1 | $2.72M | Sell |
267,577
-16,131
| -6% | -$137K | ﹤0.01% | 3598 |
|
|
2018
Q4 | $1.79M | Buy |
+283,708
| New | +$2.52M | ﹤0.01% | 3715 |
|
Other funds holding XENE
ACA
DCM
PCH
